-
Something wrong with this record ?
Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft
P.P. Osmancik, F. Bednar, L. Pavkova, P. Tousek, P. Stros, K. Jirasek
Language English Country Great Britain
Document type Comparative Study
- MeSH
- Platelet Activation MeSH
- Angioplasty, Balloon, Coronary adverse effects MeSH
- Financing, Organized MeSH
- Myocardial Ischemia blood MeSH
- Coronary Artery Bypass adverse effects MeSH
- Coronary Restenosis blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Graft Occlusion, Vascular blood MeSH
- Cross-Sectional Studies MeSH
- Myocardial Revascularization methods adverse effects MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Comparative Study MeSH
The aim of the study was to compare platelet activity between patients with an occlusion of bypass graft after coronary artery bypass graft surgery and restenosis after percutaneous coronary intervention (PCI); that is, between patients with reappearance of ischemia after two different kinds of coronary revascularization. Thirty patients were studied in a cross-sectional designed study. Fifteen of them were patients with the worst bypass graft patency from Prague-4 study (control protocol-driven coronary angiography performed at 1 year after surgery; originally 47 bypass grafts implanted, 94% of venous grafts occluded). The remaining 15 were patients with restenosis 3-12 months after PCI. Blood samples were drawn at least 12 weeks after coronary angiography. Platelet activity was determined by membrane expression of P-selectin (CD62P, % of positive cells) by flow cytometry, aggregability by ADP aggregometry. Data are expressed as mean +/- SEM. Both groups were similar with respect to age, BMI and presence of diabetes mellitus. No patient suffered from acute coronary syndrome. P-selectin expression was significantly higher in the patients with restenosis compared with patients with bypass graft occlusion (1.96 +/- 0.07 vs. 0.77 +/- 0.03, P < 0.001, Wilcoxon test). ADP aggregometry was not different between groups (55.5 +/- 1.1 vs. 56.1 +/- 0.8, P = NS). Higher platelet activity is present in the patients with restenosis after PCI compared with the patients with the occlusion of bypass graft. Platelet activity play more important role in the development of restenosis after PCI compared with the occlusion of bypass graft after coronary artery bypass graft surgery, at least in the period up to 1 year after revascularization.
- 000
- 03526naa 2200433 a 4500
- 001
- bmc11004758
- 003
- CZ-PrNML
- 005
- 20121115094503.0
- 008
- 110309s2008 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Osmančík, Pavel, $d 1972- $7 xx0104796
- 245 10
- $a Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft / $c P.P. Osmancik, F. Bednar, L. Pavkova, P. Tousek, P. Stros, K. Jirasek
- 314 __
- $a Cardiocenter, Department of Cardiology, Charles University, University Hospital Kralovske Vinohrady Prague, Czech Republic. pavel.osmancik@gmail.com
- 520 9_
- $a The aim of the study was to compare platelet activity between patients with an occlusion of bypass graft after coronary artery bypass graft surgery and restenosis after percutaneous coronary intervention (PCI); that is, between patients with reappearance of ischemia after two different kinds of coronary revascularization. Thirty patients were studied in a cross-sectional designed study. Fifteen of them were patients with the worst bypass graft patency from Prague-4 study (control protocol-driven coronary angiography performed at 1 year after surgery; originally 47 bypass grafts implanted, 94% of venous grafts occluded). The remaining 15 were patients with restenosis 3-12 months after PCI. Blood samples were drawn at least 12 weeks after coronary angiography. Platelet activity was determined by membrane expression of P-selectin (CD62P, % of positive cells) by flow cytometry, aggregability by ADP aggregometry. Data are expressed as mean +/- SEM. Both groups were similar with respect to age, BMI and presence of diabetes mellitus. No patient suffered from acute coronary syndrome. P-selectin expression was significantly higher in the patients with restenosis compared with patients with bypass graft occlusion (1.96 +/- 0.07 vs. 0.77 +/- 0.03, P < 0.001, Wilcoxon test). ADP aggregometry was not different between groups (55.5 +/- 1.1 vs. 56.1 +/- 0.8, P = NS). Higher platelet activity is present in the patients with restenosis after PCI compared with the patients with the occlusion of bypass graft. Platelet activity play more important role in the development of restenosis after PCI compared with the occlusion of bypass graft after coronary artery bypass graft surgery, at least in the period up to 1 year after revascularization.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a balónková koronární angioplastika $x škodlivé účinky $7 D015906
- 650 _2
- $a koronární bypass $x škodlivé účinky $7 D001026
- 650 _2
- $a koronární restenóza $x krev $7 D023903
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a okluze cévního štěpu $x krev $7 D006083
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a ischemická choroba srdeční $x krev $7 D017202
- 650 _2
- $a revaskularizace myokardu $x metody $x škodlivé účinky $7 D009204
- 650 _2
- $a aktivace trombocytů $7 D015539
- 650 _2
- $a financování organizované $7 D005381
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Bednář, František $7 xx0098618
- 700 1_
- $a Pávková, Leona. $7 _AN059195
- 700 1_
- $a Toušek, Petr $7 xx0105486
- 700 1_
- $a Štros, Petr $7 xx0148459
- 700 1_
- $a Jirásek, Karel $7 xx0103685
- 773 0_
- $t Blood Coagulation & Fibrinolysis $w MED00009346 $g Roč. 19, č. 8 (2008), s. 807-812
- 910 __
- $a ABA008 $b x $y 1
- 990 __
- $a 20110414093700 $b ABA008
- 991 __
- $a 20121115094520 $b ABA008
- 999 __
- $a ok $b bmc $g 832136 $s 696796
- BAS __
- $a 3
- BMC __
- $a 2008 $b 19 $c 8 $d 807-812 $m Blood coagulation & fibrinolysis $n Blood Coagul Fibrinolysis $x MED00009346
- LZP __
- $a 2011-4B/vtme